579 related articles for article (PubMed ID: 16502052)
1. Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.
Harada K; Sakai I; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Eto H; Miyake H
Int Urol Nephrol; 2006; 38(1):49-55. PubMed ID: 16502052
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
Harada K; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
[TBL] [Abstract][Full Text] [Related]
3. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
4. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
Clark PE; Stein JP; Groshen SG; Miranda G; Cai J; Lieskovsky G; Skinner DG
J Urol; 2004 Oct; 172(4 Pt 1):1342-7. PubMed ID: 15371837
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
6. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
8. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
9. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
10. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
11. Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder.
Hara S; Miyake H; Fujisawa M; Okada H; Arakawa S; Kamidono S; Hara I
Jpn J Clin Oncol; 2001 Aug; 31(8):399-402. PubMed ID: 11574634
[TBL] [Abstract][Full Text] [Related]
12. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
15. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
17. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
19. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
